FOLLOW US
NEWS
05
2021
Caliway announced the innovative abdominal fat reduction drug CBL-514 to meet primary and secondary endpoints in Phase IIa study.
CONTACT
32F.-9, No.99, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City 221, Taiwan (R.O.C.)
TEL +886-2-2697-1355
FAX +886-2-2697-2508 ; +886-2-2697-1369
info@caliwaybiopharma.com
